Cargando…
Mitochondrial Proteome Changes in Rett Syndrome
SIMPLE SUMMARY: Rett syndrome (RTT) is a genetic disorder caused by mutations in the X-chromosome. These mutations distort the function of a protein (methyl-CpG-binding protein 2), which controls the expression of several other genes. The resulting pathology, which manifests mostly in female patient...
Autores principales: | Golubiani, Gocha, van Agen, Laura, Tsverava, Lia, Solomonia, Revaz, Müller, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376342/ https://www.ncbi.nlm.nih.gov/pubmed/37508386 http://dx.doi.org/10.3390/biology12070956 |
Ejemplares similares
-
Metabolomic Fingerprint of Mecp2-Deficient Mouse Cortex: Evidence for a Pronounced Multi-Facetted Metabolic Component in Rett Syndrome
por: Golubiani, Gocha, et al.
Publicado: (2021) -
Neuronal Redox-Imbalance in Rett Syndrome Affects Mitochondria as Well as Cytosol, and Is Accompanied by Intensified Mitochondrial O(2) Consumption and ROS Release
por: Can, Karolina, et al.
Publicado: (2019) -
Myoinositol Attenuates the Cell Loss and Biochemical Changes Induced by Kainic Acid Status Epilepticus
por: Tsverava, Lia, et al.
Publicado: (2016) -
Long-Term Effects of Myoinositol on Behavioural Seizures and Biochemical Changes Evoked by Kainic Acid Induced Epileptogenesis
por: Tsverava, Lia, et al.
Publicado: (2019) -
Myo-Inositol Limits Kainic Acid-Induced Epileptogenesis in Rats
por: Kandashvili, Manana, et al.
Publicado: (2022)